Beryl Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

16.13

12.62

6.65

7.95

5.97

Operating profit

1.73

0.97

-0.13

0.54

0.68

Interest

0.22

0.24

0.21

0.22

0.23

Gross profit

1.63

0.99

-0.26

0.39

0.99

EPS (Rs)

1.59

1.10

-1.14

-0.16

0.58

Other income

0.12

0.25

0.09

0.08

0.54

Stock adjustment

-0.01

-0.02

-0.39

0.08

-0.37

Raw material

6.92

7.18

4.50

4.21

3.52

Power and fuel

-

-

-

-

-

Employee expenses

0.89

0.78

0.68

0.63

0.52

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

6.60

3.71

1.99

2.49

1.62

Provisions made

-

-

-

-

-

Depreciation

0.58

0.44

0.54

0.54

0.69

Taxation

0.25

-0.01

-0.22

-0.07

0.01

Net profit / loss

0.80

0.56

-0.58

-0.08

0.29

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

5.07

5.07

5.07

5.07

5.07

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

10.70

7.72

-1.99

6.79

11.43

GPM (%)

10.05

7.66

-3.82

4.90

15.25

NPM (%)

4.95

4.35

-8.55

-1.03

4.50